Short Interest in MariMed Inc. (OTCMKTS:MRMD) Expands By 2,327.6%

MariMed Inc. (OTCMKTS:MRMD) was the recipient of a large increase in short interest in February. As of February 27th, there was short interest totaling 24,883 shares, an increase of 2,327.6% from the February 12th total of 1,025 shares. Based on an average daily volume of 976,778 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the company’s shares are sold short. Approximately 0.0% of the company’s shares are sold short. Based on an average daily volume of 976,778 shares, the short-interest ratio is presently 0.0 days.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded MariMed from a “strong sell” rating to a “hold” rating in a report on Thursday, January 1st. One analyst has rated the stock with a Strong Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy”.

MariMed Stock Down 1.5%

Shares of MRMD stock traded down $0.00 during trading on Tuesday, hitting $0.08. 212,456 shares of the company were exchanged, compared to its average volume of 408,174. The firm has a market capitalization of $32.00 million, a price-to-earnings ratio of -2.02 and a beta of 1.11. The company has a debt-to-equity ratio of 1.34, a quick ratio of 0.35 and a current ratio of 1.06. The business’s 50-day simple moving average is $0.09 and its 200 day simple moving average is $0.11. MariMed has a twelve month low of $0.07 and a twelve month high of $0.23.

About MariMed

MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.